Psilocybin: promising results in double-blind trials require confirmation by real-world evidence December 6, 2016
Antisuicidal Response Following Ketamine Infusion Is Associated With Decreased Nighttime Wakefulness in Major Depressive Disorder and Bipolar Disorder December 6, 2016
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial December 1, 2016
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial December 1, 2016
Psilocybin for anxiety and depression in cancer care? Lessons from the past and prospects for the future December 1, 2016
